Clarence-Smith K - Search Results

1

Double-blind randomized treatment of poststroke depression using nefiracetam.

Robinson RG, Jorge RE, Clarence-Smith K. Robinson RG, et al. Among authors: clarence smith k. J Neuropsychiatry Clin Neurosci. 2008 Spring;20(2):178-84. doi: 10.1176/jnp.2008.20.2.178. J Neuropsychiatry Clin Neurosci. 2008. PMID: 18451188 Clinical Trial.

2

Double-blind treatment of apathy in patients with poststroke depression using nefiracetam.

Robinson RG, Jorge RE, Clarence-Smith K, Starkstein S. Robinson RG, et al. Among authors: clarence smith k. J Neuropsychiatry Clin Neurosci. 2009 Spring;21(2):144-51. doi: 10.1176/jnp.2009.21.2.144. J Neuropsychiatry Clin Neurosci. 2009. PMID: 19622685 Clinical Trial.

3

Donepezil Plus Solifenacin (CPC-201) Treatment for Alzheimer's Disease.

Chase TN, Farlow MR, Clarence-Smith K. Chase TN, et al. Among authors: clarence smith k. Neurotherapeutics. 2017 Apr;14(2):405-416. doi: 10.1007/s13311-016-0511-x. Neurotherapeutics. 2017. PMID: 28138837 Free PMC article. Clinical Trial.

4

A clinical trial of progesterone for severe traumatic brain injury.

Skolnick BE, Maas AI, Narayan RK, van der Hoop RG, MacAllister T, Ward JD, Nelson NR, Stocchetti N; SYNAPSE Trial Investigators. Skolnick BE, et al. N Engl J Med. 2014 Dec 25;371(26):2467-76. doi: 10.1056/NEJMoa1411090. Epub 2014 Dec 10. N Engl J Med. 2014. PMID: 25493978 Free article. Clinical Trial.

5

Safety and Efficacy of Tetrabenazine and Use of Concomitant Medications During Long-Term, Open-Label Treatment of Chorea Associated with Huntington's and Other Diseases.

Shen V, Clarence-Smith K, Hunter C, Jankovic J. Shen V, et al. Among authors: clarence smith k. Tremor Other Hyperkinet Mov (N Y). 2013 Oct 22;3:tre-03-191-4337-1. doi: 10.7916/D8BK1B2D. eCollection 2013. Tremor Other Hyperkinet Mov (N Y). 2013. PMID: 24255799 Free PMC article.

6

Use of Tetrabenazine in Huntington Disease Patients on Antidepressants or with Advanced Disease: Results from the TETRA-HD Study.

Dorsey R, Biglan K, Eberly S, Auinger P, Brocht A, Umeh CC, Oakes D, Clarence-Smith K, Marshall F, Shoulson I, Frank S. Dorsey R, et al. Among authors: clarence smith k. PLoS Curr. 2011 Nov 13;3:RRN1283. doi: 10.1371/currents.RRN1283. PLoS Curr. 2011. PMID: 22139861 Free PMC article.

7

Tetrabenazine for the treatment of chorea and other hyperkinetic movement disorders.

Jankovic J, Clarence-Smith K. Jankovic J, et al. Among authors: clarence smith k. Expert Rev Neurother. 2011 Nov;11(11):1509-23. doi: 10.1586/ern.11.149. Expert Rev Neurother. 2011. PMID: 22014129 Review.

8

The effect of vesnarinone on TNF alpha production in human peripheral blood mononuclear cells and microglia: a preclinical study for the treatment of multiple sclerosis.

Jiang H, Bielekova B, Okazaki H, Clarence-Smith K, Johnson KP, Bergey G, Martin R, Dhib-Jalbut S. Jiang H, et al. Among authors: clarence smith k. J Neuroimmunol. 1999 Jun 1;97(1-2):134-45. doi: 10.1016/s0165-5728(99)00037-5. J Neuroimmunol. 1999. PMID: 10408967

9

Parkinson's disease: neurodegenerative mechanisms and neuroprotective interventions--report of a workshop.

Fahn S, Clarence-Smith KE, Chase TN. Fahn S, et al. Among authors: clarence smith ke. Mov Disord. 1998 Sep;13(5):759-67. doi: 10.1002/mds.870130502. Mov Disord. 1998. PMID: 9756143 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results